Kari Pekka Pitkänen
Director/Miembro de la Junta en Scellex Oy .
Fortuna: 5 M $ al 30/04/2024
Perfil
Kari Pekka Pitkänen founded Aiforia Technologies Oyj in 2013, where he worked as Director-Business Development from 2021 to 2023.
Mr. Pitkänen also currently works at Scellex Oy, as Director from 2019 and Genna Health Oy, as Director from 2020.
Mr. Pitkänen also formerly worked at Finnzymes Oy, as Marketing Director.
Mr. Pitkänen received his graduate degree from Aalto University School of Science & Technology.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 31/08/2023 | 1 181 000 ( 4.55% ) | 5 M $ | 30/04/2024 |
Cargos activos de Kari Pekka Pitkänen
| Empresas | Cargo | Inicio |
|---|---|---|
| Scellex Oy | Director/Miembro de la Junta | 01/01/2019 |
| Genna Health Oy | Director/Miembro de la Junta | 01/01/2020 |
Antiguos cargos conocidos de Kari Pekka Pitkänen.
| Empresas | Cargo | Fin |
|---|---|---|
| AIFORIA TECHNOLOGIES OYJ | Fundador | 01/01/2023 |
Finnzymes Oy
 Finnzymes Oy Pharmaceuticals: MajorHealth Technology The company is part of Thermo Fisher Scientific, the world leader in serving science. Thermo Fisher Scientific enables customers to make the world healthier, cleaner and safer by providing analytical instruments, equipment, reagents and consumables, software and services for research, analysis, discovery and diagnostics. With annual sales of more than $9 billion, Thermo Fisher Scientific has over 30,000 employees and serves more than 350,000 customers in pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies as well as environmental, industrial quality and process control settings. Finnzymes, founded in 1986, is a leader in the development of PCR, quantitative real-time PCR, transposon and RNA technologies. Its aim is to develop products which make the difference, products that deliver results not achievable otherwise. | Ventas & Marketing | - |
Formación de Kari Pekka Pitkänen.
| Aalto University School of Science & Technology | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| AIFORIA TECHNOLOGIES OYJ | Technology Services |
| Empresas privadas | 3 |
|---|---|
Finnzymes Oy
Finnzymes Oy Pharmaceuticals: MajorHealth Technology The company is part of Thermo Fisher Scientific, the world leader in serving science. Thermo Fisher Scientific enables customers to make the world healthier, cleaner and safer by providing analytical instruments, equipment, reagents and consumables, software and services for research, analysis, discovery and diagnostics. With annual sales of more than $9 billion, Thermo Fisher Scientific has over 30,000 employees and serves more than 350,000 customers in pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies as well as environmental, industrial quality and process control settings. Finnzymes, founded in 1986, is a leader in the development of PCR, quantitative real-time PCR, transposon and RNA technologies. Its aim is to develop products which make the difference, products that deliver results not achievable otherwise. | Health Technology |
| Scellex Oy | |
| Genna Health Oy |
- Bolsa de valores
- Insiders
- Kari Pekka Pitkänen